Trading in CellaVision shares will commence today on First North in Sweden.
Including CellaVision, First North now comprises 95 companies.
CellaVision AB develops and markets products for the health care sector,
enabling blood cell analysis and quality assurance of morphology diagnosis.
“We warmly welcome CellaVision to First North. CellaVision is the eighteenth
company to join First North this year and the company is a valuable
contribution to our Health Care sector”, says Jenny Rosberg, President of
Company Services at OMX.
Remium AB is Certified Adviser for CellaVision. A round lot of shares in
CellaVision, whose short name is CEVI, amounts to 500 and the company is
included in the Health Care sector.
For further information, please contact
Jonas Rodny, OMX Nordic Exchange +46 8 405 72 67
About OMX | OMX is a leading expert in the exchange industry. Through the
Nordic Exchange, OMX offers access to approximately 80 percent of the Nordic
and Baltic securities market. The Nordic Exchange is a term used for marketing
purposes and is not a legal entity. It describes the common offering from the
Helsinki Stock Exchange, Copenhagen Stock Exchange, Stockholm Stock Exchange,
Iceland Stock Exchange, Tallinn Stock Exchange, Riga Stock Exchange and Vilnius
Stock Exchange. OMX integrated technology solutions cross the transaction chain
enabling efficient securities transactions for over 60 exchange organizations
in more than 50 countries. OMX is a Nordic Large Cap company in the Financials
sector on the OMX Nordic Exchange. For more information, please visit
www.omxgroup.com.
